{"id":780844,"date":"2026-02-22T04:56:23","date_gmt":"2026-02-22T04:56:23","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/780844\/"},"modified":"2026-02-22T04:56:23","modified_gmt":"2026-02-22T04:56:23","slug":"ips-cell-based-products-win-conditional-approval-from-health-ministry-panel","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/780844\/","title":{"rendered":"iPS cell-based products win conditional approval from health ministry panel"},"content":{"rendered":"<p>A health ministry panel has given conditional approval to two medical products derived from iPS cells, paving the way for the world\u2019s first commercialization of Nobel Prize-winning stem cell research.<\/p>\n<p>But Thursday\u2019s endorsement of the products \u2014 neurons for Parkinson\u2019s disease and muscle patches for severe heart disease \u2014 was based on small-scale clinical studies that confirmed only their safety and \u201cpresumed\u201d their efficacy.<\/p>\n<p>The manufacturers must conduct postmarket clinical trials to see if they actually work. If the efficacy is not fully proven, the ministry will withdraw approval within seven years.<\/p>\n","protected":false},"excerpt":{"rendered":"A health ministry panel has given conditional approval to two medical products derived from iPS cells, paving the&hellip;\n","protected":false},"author":2,"featured_media":780845,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[4316],"tags":[105,4348,107577,34696,16,15],"class_list":["post-780844","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-health","tag-healthcare","tag-ips","tag-parkinson","tag-uk","tag-united-kingdom"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/116112509155041902","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/780844","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=780844"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/780844\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/780845"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=780844"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=780844"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=780844"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}